Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma

Strahlentherapie und Onkologie

Volumn 179, Issue 4, 2003, Pages 233-240

  Eich, Hans Theodor ^a   Hero, Barbara ^a   Staar, Susanne ^a   Micke, Oliver ^b   Seegenschmiedt, Heinrich ^c   Mattke, Adrian ^d   Berthold, Frank ^a   Müller, Rolf Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c ALFRIED KRUPP KRANKENHAUS   (Germany)

^d Children's Hospital   (Germany)

Author keywords

Chemotherapy; Esthesioneuroblastoma; Multimodality therapy; Neuroectodermal tumors; Olfactory neuroblastoma; Radiotherapy; Surgery

Indexed keywords

CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; PLATINUM DERIVATIVE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ADULT; AGED; AMENORRHEA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; ESTHESIONEUROBLASTOMA; FACE ASYMMETRY; FEMALE; HEARING DISORDER; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PERIPHERAL NEUROPATHY; SCHOOL CHILD; SENSORY DYSFUNCTION; SMELLING; TUMOR CLASSIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; DISEASE-FREE SURVIVAL; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0344837767     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1089-x     Document Type: Article

References (41)

1. Berger RL, Luc R. L'esthesioneuroepitheliome olfactif. Bull Assoc Franc Etude Cancer 1924;13:410-20.
2. Bhattacharyya N, Thornten AF, Joseph MP, et al. Successful treatment of esthesioneuroblastoma and neurocrine carcinoma with combined chemotherapy and proton radiation. Arch Otolaryngol Head Neck Surg 1997;123:34-40.
3. Biller HF, Lawson W, Sachdev VP, et al. Esthesioneuroblastoma. Surgical treatment without radiation. Laryngoscope 1990;100:1199-201.
4. Bilsky MH, Kraus DH, Strong EW, et al. Extended anterior craniofacial resection for intracranial extension of malignant tumors. Am J Surg 1997;174:565-8.
5. Bobele GB, Sexauer C, Barnes PA, et al. Esthesioneuroblastoma presenting as an orbital mass in a young child. Med Pediatr Oncol 1994;22:269-73.
6. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastomas: a general review of the cases published since the discovery of the tumor in 1924. Anticancer Res 1997;17:2683-706.
7. Dawe CJ. Neoplasms induced by polyomavirus virus in the upper respiratory tract of mice. In: Muir CS, Shanmugaratnam K, eds. Cancer of the rhinopharynx. Copenhagen: Munksgaard, 1967:179-96.
8. Debus J, Haberer T, Schulz-Ertner D, et al. Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives. Strahlenther Onkol 2000;176:211-6.
9. Dulgnerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1979-1990. Laryngoscope 1992;102:843-8.
10. Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma. Long-term outcome and patterns of failure - the University of Virginia experience. Cancer 1994;73:2556-62.
11. Eich HT, Staar S, Micke O, et al. Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 2001;49:155-60.
12. Elkon D, Hightower SI, Lim ML, et al. Esthesioneuroblastoma. Cancer 1979;44:1087-94.
13. Eriksen JG, Bastholt L, Krogdahl AS, et al. Esthesioneuroblastoma. What is the optimal treatment? Acta Oncol 2000;39:231-5.
14. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:835-42.
15. Guedea F, Van Limbergen E, Van den Bogaert W. High dose level radiation therapy for local tumor control in esthesioneuroblastoma. Eur J Cancer 1994;30:1757-60.
16. Herrold KM. Induction of olfactory neuroepithetial tumors and Syrian hamsters by diethylnitrosamine. Cancer 1964;17:114-21.
17. Herzog J, Schmidt B, Peterson D, et al. Das Neuroblastom des Nervus olfactorius. Strahlentherapeutische Erfahrungen an sechs Patienten. Strahlenther Onkol 1988;164:515-26.
18. Hug EB, Muenter MW, Archambeau JD, et al. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 2002;178:10-7.
19. Hyams VJ. Olfactory neuroblastoma (case 6). In: Batsakis JG, Hyams VJ, Morales AR, eds. Special tumors of the head and neck. Chicago: American Society of Clinical Pathologists, 1983:24-9.
20. Jekunen AP, Kairemo KJ, Lehtonen HP, et al. Treatment of olfactory neuroblastoma. A report of 11 cases. Am J Clin Oncol 1996;19:375-8.
21. Kadish S, Godman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976;37:1571-6.
22. Kaplan EL, Meier P.: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-84.
23. Koike K, Jay G, Hartley JW, et al. Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastomas. J Virol 1990;64:3988-91.
24. Koka VN, Julieron M, Bourhis J, et al. Aesthesioneuroblastoma. J Laryngol Otol 1998;112:628-33.
25. Kortmann RD, Kuhl J, Timmermann B, et al. Actual and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET and intracranial germ cell tumors in children. Strahlenther Onkol 2001;177:447-61.
26. Lochrin C. Esthesioneuroblastoma. Med Pediatr Oncol 1989;17:433-8.
27. McElroy EA, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998;42:1023-7.
28. Mendeloff J. The olfactory neuroepithelial tumors. Cancer 1957;10:944-56.
29. Morita A, Ebersold MJ, Olsen KD, et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-14.
30. Nguyen QA, Villablanca JG, Siegel SE, et al. Esthesioneuroblastoma in the pediatric age-group: the role of chemotherapy and autologous bone marrow transplantation. Int J Pediatr Otorhinolaryngol 1996;37:45-52.
31. O'Connor TA, McLean P, Juillard GJF, et al. Olfactory neuroblastoma. Cancer 1989;63:2426-8.
32. Polin RS, Sheehan JP, Chenelle AG, et al. The role of adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998;42:1029-37.
33. Schrenzel MD, Higgins RJ, Hinrichs SH, Smith MO, Torten M. Type C retroviral expression in sponataneous feline olfactory neuroblastomas. Acta Neuropathol (Berl) 1990;80:547-53.
34. Sheehan JM, Sheehan JP, Jane JA, et al. Chemotherapy for esthesioneuroblastoma. Neurosurg Clin North Am 2000;11:693-701.
35. Slevin NJ, Irwin CJ, Banerjee SS, et al. Olfactory neural tumors - the role of external beam radiotherapy. J Laryngol Otol 1996;110:1012-6.
36. Spaulding CA, Kranyak MS, Constable WC, et al. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988;15:581-90.
37. Stewart FM, Lazarus HM, Levine PA, et al. High-dose chemotherapy and autologous marrow transplantation for esthesioneuroblastoma and sinonasal undifferentiated carcinoma. Am J Clin Oncol 1989;12:217-21.
38. Strnad V, Grabenbauer GG, Dunst J, et al. Radiotherapie beim Ästhesioneuroblastom. Strahlenther Onkol 1994;170:79-84.
39. Vollrath M, Altmannsberger M. Ästhesioneuroblastom: Histogenese und Diagnose. Strahlenther Onkol 1989;165:461-7.
40. Wade PM, Smith RE, Johns ME. Response of esthesioneuroblastoma to chemotherapy: report of five cases and review of the literature. Cancer 1984;53:1036-41.
41. Zabel A, Thilmann C, Milker-Zabel S, et al. The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlenther Onkol 2002;178:187-91.